Catalyst Wire Dossier Catalyst Wire Dossier

VISINE ALLERGY EYE RELIEF MULTI-ACTION

Naphazoline hydrochloride and pheniramine maleate · Kenvue Brands LLC
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for VISINE ALLERGY EYE RELIEF MULTI-ACTION, covering 2012-12-18 to 2025-10-22. Get the full timeline:

Most recent: FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)

See pricing